Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics

NCT01562431 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT01562431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01562431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2011
Completion date
June 30, 2013
Enrollment
246 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer genetics, psychosocial issues